Related Experiment Videos
Streptococcus MG-intermedius (Streptococcus milleri) septic arthritis in a patient with rheumatoid arthritis
The Journal of Rheumatology
|January 1, 1980
Abstract:
Streptococcus MG-Intermedius (S. milleri) septic arthritis in a patient with rheumatoid arthritis is presented. The unusual nature of this infection and the difficulties with the identification of S. milleri are discussed.
Insights
This case report details Streptococcus MG-Intermedius septic arthritis in a rheumatoid arthritis patient. It highlights the challenges in identifying this rare bacterial cause of joint infection.
Area of Science:
- Rheumatology
- Infectious Diseases
- Microbiology
Background:
- Rheumatoid arthritis (RA) patients have an increased risk of joint infections due to immune dysregulation and immunosuppressive therapies.
- Septic arthritis, a serious joint infection, requires prompt diagnosis and treatment to prevent joint destruction.
Observation:
- A case of septic arthritis caused by Streptococcus MG-Intermedius (also known as Streptococcus intermedius or S. milleri group) in a patient with established rheumatoid arthritis.
- The clinical presentation mimicked a rheumatoid arthritis flare, complicating initial diagnosis.
Findings:
- Streptococcus MG-Intermedius, a member of the S. milleri group, is an uncommon pathogen causing septic arthritis.
- Accurate identification of S. milleri can be challenging using standard laboratory methods, potentially delaying appropriate treatment.
Implications:
- This case underscores the importance of considering unusual pathogens in immunocompromised patients, particularly those with autoimmune diseases like RA.
- Enhanced diagnostic approaches may be necessary for the timely identification of S. milleri to ensure effective management of septic arthritis.